The goal of The Summit is to offer stakeholders in the healthcare innovation ecosystem a place to CONNECT – EXPLORE – INVEST – GROW
Poland has already invested great funds in this emerging economy, for building the ecosystem, and intends to continue to offer funding to encourage the growth of this industry. Polish healthcare expenditures amount to approx. 24 billion EUR!
- In the new financial plan for 2016 to 2020, approximately 2.4 billion EUR will be allocated forfinancing the healthcare sector.
- The country’s Ministry of Science and Higher Education also budgeted 302 million EUR forbiotechnology development.
- Clinical trials have experienced an increase in the last years, due to innovation-friendly policiesand incentives.
- Poland is becoming an emerging hotspot for pharmaceutical companies and biotech startups.
- Poland’s pharmaceutical sector worth approximately eight billion EUR.
- Poland’s medical technology sector is valued at approx. 1.6 billion EUR and is expected to grow 10percent annually in the coming three years.
As the Polish start-up ecosystem is thriving and as the Polish Healthcare and Biotech industries continue to grow – we firmly believe that there is a need for a space where members of these industries can share their stories, and therefore we created EU-MED Summit, with a rich and exciting program covering different aspects of business, brand, start-up, companies, marketing, and cutting-edge technologies.
Konferencja EU-MED Summit 2019 speakers
- BEN AMI Doron CEO ShizimXL
- BORNSTEIN Yossi Founder, CEO of Shizim Group
- BRONCEL Adam Poland Ventures, Managing Partner
- CIEŚLAK Marek CEO, BIONANOPARK Science and Technology Park
- CIMOSZKO SKOWRONSKI Boguslawa (Bogy) Board Member, MIT Enterprise Forum Central & Eastern Europe
- DARVISH Nissim Senior Managing Director at OrbiMed Advisors
- DASTYCH Jarosław CEO, Proten Pharmaceuticals
- EMILEWICZ Jadwiga Minister of Entrepreneurship and Technology
- FERNANDEZ Tania Founder & CEO, DreamCatcher Ventures
- GADOT Harel Company Group Chairman; MEDX Ventures Group CEO; Microbot Medical, INC Nasdaq: MBOT
- GENSIOR Sebastian Managing Director of Global Health Access Solutions
- GROBELSKI Bartłomiej Medical University of Lodz, Director of the Centre for Innovation and Technology Transfer
- GURDAŁA Mikołaj Director of Innovation in the Northern and Central European Region, EIT Health InnoStars
- JAROS Sławomir Member of the Board and CSO, COO, Mabion
- JAROSZ Jerzy Doctor of the Oncological Hospice Foundation in Warsaw
- KLEINA Artur CEO, Bio-Gen
- KUC Włodzimierz Director at the Department for R&D Investments, NCBR
- LACHOWSKI Slawomir Chairman & CEO, G-Rock Ltd
- MATAN Avi General Manager, Poland, Novartis Oncology
- MIDDELMANN Isaac Venture Centre of Excellence, Project Manager, EIT Health France
- MOKRZYCKI Aleksander PFR Ventures sp. z o.o
- MUSIAŁEK Jakub Steering Committee
- OPHIR Yael Executive Director, HealthIL
- PAMPUCH Bartosz CEO, Comarch Healthcare
- PARDO Tamir Chairman of Shizim Group, the Former Director of the Mossad
- PUSTELNIK Adam Advisor to the Mayor of the City of Łódź for Economic Development
- RIESKE Piotr CSO, Celther; CEO, Personather
- SADILEK Tomas Director of Governmental Affairs, ICCI (International Cannabis and Cannabinoids Institute)
- SAÏ Caroline, A. Operations Manager Angels Santé, EIT Health Investor Network Leader
- SCHLATMANN Reinier CEO of Philips Central and Eastern Europe
- STOLAR Orit Pediatric Neurologist, Autism Center of Alut, Shamir Medical Center, Israel
- SURACE Filippo Founder and CEO at Cube-Labs a Life Sciences Incubator and Accelerator
- SZALOKI Katalin Public Affairs Lead, EIT Health InnoStars
- WOZNIAK Lucyna Vice-Rector Medical University of Lodz
- YOSEFI Ariel Partner, Co-Head of Technology & Regulation Department, Herzog Fox & Neeman
- ZIEŃ Piotr Innovation and Science Director, Polpharma Biologics
Kenes Group
DoubleTree by Hilton Łódź, Łąkowa 29, 90-554 Łódź